Skip to content

Live Events

Live Events

Live Events

Live Events

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,601 - 1,625 of 2,995

«
1
…
63
64
65
66
67
…
120
»

EGFR Mutated Lung Cancer - Advanced Stage

EGFR Mutated Lung Cancer - Advanced Stage

By: David Gandara, MD

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

By: David Gandara, MD

Predictive Biomarkers for Immunotherapy: Non-Small Cell Lung Cancer as a Model of Tumor Heterogeneity

Predictive Biomarkers for Immunotherapy: Non-Small Cell Lung Cancer as a Model of Tumor Heterogeneity

By: David Gandara, MD

EGFR Mutated Lung Cancer - Advanced Stage

EGFR Mutated Lung Cancer - Advanced Stage

By: David Gandara, MD

Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers

Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers

By: David Gandara, MD

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC

By: David Gandara, MD

EGFR Mutated Lung Cancer - Advanced Stage

EGFR Mutated Lung Cancer - Advanced Stage

By: David Gandara, MD

EGFR Mutated Lung Cancer - Advanced Stage

EGFR Mutated Lung Cancer - Advanced Stage

By: David Gandara, MD

PD-1 / PD-L1 Directed Immunotherapy for Advanced NSCLC

PD-1 / PD-L1 Directed Immunotherapy for Advanced NSCLC

By: David Gandara, MD

PD-1 / PD-L1 Directed Immunotherapy for Advanced NSCLC

PD-1 / PD-L1 Directed Immunotherapy for Advanced NSCLC

By: David Gandara, MD

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

By: David Gandara, MD

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

By: David Gandara, MD

Optimal Surgical Approach in Early Stages NSCLC

Optimal Surgical Approach in Early Stages NSCLC

By: David H. Harpole, Jr., MD

Optimal Surgical Approach in Early Stages NSCLC

Optimal Surgical Approach in Early Stages NSCLC

By: David H. Harpole, Jr., MD

Small Cell Lung Cancer: Novel Approaches 2019

Small Cell Lung Cancer: Novel Approaches 2019

By: David R. Gandara - MD

Current Issues in Checkpoint Immunotherapy for NSCLC

Current Issues in Checkpoint Immunotherapy for NSCLC

By: David R. Gandara, MD

Current Issues in Checkpoint Immunotherapy for NSCLC

Current Issues in Checkpoint Immunotherapy for NSCLC

By: David R. Gandara, MD

Small Cell Lung CancerNovel Approaches 2019

Small Cell Lung CancerNovel Approaches 2019

By: David R. Gandara, MD

Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020

Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020

By: David R. Gandara, MD

Emerging Biomarkers for Immunotherapy in NSCLC

Emerging Biomarkers for Immunotherapy in NSCLC

By: David R. Gandara, MD

Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers

Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers

By: David R. Gandara, MD

Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020

Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020

By: David R. Gandara, MD

By: David R. Gandara, MD.

By: David R. Gandara, MD.

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

By: David T. Cooke, MD

«
1
…
63
64
65
66
67
…
120
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok